← ANALYST RATINGS · TIPRANKS
Veeva Systems (VEEV): analyst forecast and price target
Analyst consensus
Moderate Buy17 Buy6 Hold1 Sell
Ratings of 24 analysts in the last 3 months12-month forecast
Based on 24 price targets given in the last 3 months, the average target is $294, the highest $340, the lowest $180. The average is −5.4% from the last price of $310.
Analyst ratings 27
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Software - ApplicationxAI Grok-3 | TipRanks - xAI | $363 → $360−0.8% | Buy | +16.0% | Reiterated | 17.10.26on TipRanks 07:05 | — | |
| AI DeepSeek Software - ApplicationDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $362 → $358−1.1% | Buy | +15.3% | Reiterated | 17.10.26on TipRanks 07:05 | — | |
| AI OpenAI Software - ApplicationOpenAI 5.2 | TipRanks - OpenAI | $360 → $357−0.8% | Buy | +15.0% | Reiterated | 17.10.26on TipRanks 07:05 | — | |
| AI Anthropic Software - ApplicationAnthropic Opus-4.5 | TipRanks - Anthropic | $366 → $363−0.8% | Buy | +17.0% | Reiterated | 17.10.26on TipRanks 07:05 | — | |
| AI Google Software - ApplicationGemini 3-pro | TipRanks - Google | $366 → $363−0.8% | Buy | +17.0% | Reiterated | 17.10.26on TipRanks 07:05 | — | |
| AI PerPlexity Software - ApplicationPerPlexity SonarPro | TipRanks - PerPlexity | $368 → $365−0.8% | Buy | +17.6% | Reiterated | 17.10.26on TipRanks 07:05 | — | |
| Joseph Vruwink★★★★★★★★★★#1159 · hits 59% · avg +7.8% | Robert W. Baird | $300 | Buy | −3.3% | Reiterated | 09.10.26on TipRanks 08:50 | +3.4%next day 0.0% · 5 days +6.8% | ↗ |
| Stan Berenshteyn★★★★★★★★★★#11485 · hits 50% · avg −5.0% | Wells Fargo | $330 | Buy | +6.3% | Reiterated | 30.09.26on TipRanks Oct 1 05:30 | +2.7%next day −1.4% · 5 days −2.9% | ↗ |
| Craig Hettenbach★★★★★★★★★★#1537 · hits 59% · avg +7.6% | Morgan Stanley | $275 | Hold | −11.4% | Assigned | 18.09.26on TipRanks 08:25 | −1.5%next day −1.1% · 5 days +6.6% | ↗ |
| Unknown Analyst | CFRA | — | Buy | — | Upgrade | 16.09.26on TipRanks Sep 18 08:25 | −0.2%next day −1.6% · 5 days +0.1% | ↗ |
| Charles Rhyee★★★★★★★★★★#1937 · hits 54% · avg +5.6% | TD Cowen | $283 | Buy | −8.8% | Reiterated | 15.09.26on TipRanks 14:50 | +0.8%next day −0.2% · 5 days −4.5% | ↗ |
| Alexei Gogolev★★★★★★★★★★#2483 · hits 54% · avg +6.0% | J.P. Morgan | $299 | Buy | −3.7% | Reiterated | 01.09.26on TipRanks Sep 2 08:05 | −1.6%next day +0.1% · 5 days −6.7% | ↗ |
| Tyler Radke★★★★★★★★★★#2747 · hits 50% · avg +4.2% | Citi | $190 → $273+43.7% | Hold | −12.0% | Reiterated | 28.08.26on TipRanks 06:30 | −1.7%next day +3.6% · 5 days −0.7% | ↗ |
| Karl Keirstead★★★★★★★★★★#437 · hits 63% · avg +14.6% | UBS | $190 → $290+52.6% | Hold | −6.6% | Assigned | 28.08.26on TipRanks Aug 27 07:15 | +14.5%next day −1.7% · 5 days +0.5% | ↗ |
| Brian Peterson★★★★★★★★★★#2160 · hits 49% · avg +5.3% | Raymond James | $225 → $330+46.7% | Buy | +6.3% | Reiterated | 27.08.26on TipRanks 08:31 | +14.5%next day −1.7% · 5 days +0.5% | ↗ |
| Kenneth Wong★★★★★★★★★★#1613 · hits 52% · avg +7.5% | Oppenheimer | $300 → $325+8.3% | Buy | +4.7% | Reiterated | 27.08.26on TipRanks 08:30 | +14.5%next day −1.7% · 5 days +0.5% | ↗ |
| Kirk Materne★★★★★★★★★★#1369 · hits 56% · avg +7.7% | Evercore ISI | $185 → $250+35.1% | Hold | −19.4% | Reiterated | 27.08.26on TipRanks 08:00 | +14.5%next day −1.7% · 5 days +0.5% | ↗ |
| Sean Dodge★★★★★★★★★★#11980 · hits 43% · avg −4.3% | BMO Capital | $175 → $270+54.3% | Hold | −13.0% | Assigned | 27.08.26on TipRanks 07:25 | +14.5%next day −1.7% · 5 days +0.5% | ↗ |
| Steven Valiquette★★★★★★★★★★#8240 · hits 53% · avg 0.0% | Mizuho Securities | $270 → $280+3.7% | Buy | −9.8% | Reiterated | 27.08.26on TipRanks 07:20 | +14.5%next day −1.7% · 5 days +0.5% | ↗ |
| David Hynes★★★★★★★★★★#12301 · hits 38% · avg −10.3% | Canaccord Genuity | $220 → $260+18.2% | Hold | −16.2% | Reiterated | 27.08.26on TipRanks 07:05 | +14.5%next day −1.7% · 5 days +0.5% | ↗ |
| Name not given | — | $276 → $310+12.3% | Buy | −0.1% | Reiterated | 27.08.26on TipRanks 07:05 | +14.5%next day −1.7% · 5 days +0.5% | ↗ |
| David Grossman★★★★★★★★★★#4304 · hits 49% · avg +2.3% | Stifel Nicolaus | $275 → $300+9.1% | Buy | −3.3% | Reiterated | 27.08.26on TipRanks 06:50 | +14.5%next day −1.7% · 5 days +0.5% | ↗ |
| Billy Fitzsimmons★★★★★★★★★★#3245 · hits 63% · avg +9.3% | Piper Sandler | $295 → $320+8.5% | Buy | +3.1% | Reiterated | 27.08.26on TipRanks 06:45 | +14.5%next day −1.7% · 5 days +0.5% | ↗ |
| Ryan MacDonald★★★★★★★★★★#12366 · hits 37% · avg −11.1% | Needham | $310 | Buy | −0.1% | Reiterated | 27.08.26on TipRanks 06:45 | +14.5%next day −1.7% · 5 days +0.5% | ↗ |
| Dylan Becker★★★★★★★★★★#3415 · hits 50% · avg +3.7% | William Blair | — | Buy | — | Reiterated | 27.08.26on TipRanks 06:25 | +14.5%next day −1.7% · 5 days +0.5% | ↗ |
| Saket Kalia★★★★★★★★★★#966 · hits 56% · avg +9.0% | Barclays | $275 → $315+14.5% | Buy | +1.5% | Reiterated | 27.08.26on TipRanks Aug 26 04:15 | −0.8%next day +14.5% · 5 days +14.7% | ↗ |
| Gabriela Borges★★★★★★★★★★#817 · hits 59% · avg +13.8% | Goldman Sachs | $165 → $180+9.1% | Sell | −42.0% | Reiterated | 26.08.26on TipRanks Aug 27 08:10 | −0.8%next day +14.5% · 5 days +14.7% | ↗ |
| Rishi Jaluria★★★★★★★★★★#11899 · hits 52% · avg −4.1% | RBC Capital | $275 → $325+18.2% | Buy | +4.7% | Reiterated | 26.08.26on TipRanks Aug 27 07:25 | −0.8%next day +14.5% · 5 days +14.7% | ↗ |
| David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% | BTIG | $340 | Buy | +9.6% | Reiterated | 26.08.26on TipRanks Aug 27 07:10 | −0.8%next day +14.5% · 5 days +14.7% | ↗ |
| Jailendra Singh★★★★★★★★★★#12131 · hits 43% · avg −6.4% | Truist Financial | — | Buy | — | Reiterated | 26.08.26on TipRanks 08:07 | −0.8%next day +14.5% · 5 days +14.7% | ↗ |
| Unknown Analyst | Stephens | $324 | Buy | +4.4% | Reiterated | 05.03.26on TipRanks 07:35 | +4.6%next day +1.0% · 5 days −5.6% | ↗ |
| Bradley Sills★★★★★★★★★★#6686 · hits 44% · avg +0.6% | Bank of America Securities | $304 | Hold | −2.0% | Reiterated | 04.03.26on TipRanks Mar 5 06:11 | +0.7%next day +4.6% · 5 days +0.5% | ↗ |
| Scott Schoenhaus★★★★★★★★★★#12104 · hits 35% · avg −9.7% | KeyBanc | — | Hold | — | Downgrade | 12.12.25on TipRanks 04:10 | −1.6%next day −1.3% · 5 days −0.8% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Veeva Systems
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $294 at a price of $285 (+2.8%); now: $294 at $310 (−5.4%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 10 | 11 | 9 | 2 | 1 |
| Buy | 13 | 13 | 15 | 39 | 35 | 33 |
| Hold | 7 | 8 | 7 | 13 | 7 | 7 |
| Sell | 1 | 1 | 1 | 2 | 1 | 1 |
Earnings and sales forecast
Next report: 26.11.26 (Q3 2027, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $2.34 (from $2.32 to $2.40). Last quarter: $2.35.
Sales
Next quarter’s sales estimate — $935M (from $932M to $945M). Last quarter: $928M.
Best top-analyst consensus in the sector · Healthcare
About Veeva Systems
- CEO: Peter Gassner
- Employees: 7,928
- 4280 Hacienda Drive, Pleasanton, CA, 94588, US
- www.veeva.com
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on da
Data from the stock’s TipRanks forecast page, read 22 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗